← back to search

Alexandra Savell

Amyotrophic Lateral Sclerosis Therapy Development Institute ·
Area of research
Hematology · Genetics
Research interest
Research interests include Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research, Monoclonal and Polyclonal Antibodies Research, and Protein Degradation and Inhibitors.
h-index
15
citations
1,470
works
58
NIH funding
—
primary concept
Lenalidomide
email
✉ Find email ↗

Recent publications

Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma
Cancer Cell 2022cited by 61position: middledoi
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation
Blood 2021cited by 42position: middledoi
A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation
Blood 2020cited by 97position: middledoi
Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial
The Lancet Haematology 2019cited by 72position: middledoi
Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma
Blood 2018cited by 24position: middledoi
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
New England Journal of Medicine 2016cited by 591position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Haesook T. Kim · Harvard University2 papers (2019–2020)Philippe Armand · Harvard University2 papers (2019–2020)Matthew S. Davids · Harvard University2 papers (2019–2020)Sarah Nikiforow · Harvard University1 papers (2020–2020)— · 1 papers (2019–2019)Jerome Ritz · Harvard University1 papers (2020–2020)Svitlana Tyekucheva · Harvard University1 papers (2019–2019)— · 1 papers (2019–2019)— · 1 papers (2019–2019)Jennifer R. Brown · Harvard University1 papers (2019–2019)Jon Arnason · Harvard University1 papers (2019–2019)Ronald W. Takvorian · Center for Cancer Research1 papers (2019–2019)Rodrigo Maegawa · Janssen Scientific Affairs (United States)1 papers (2020–2020)Frederick L. Locke · Moffitt Cancer Center1 papers (2020–2020)Corey Cutler · Harvard University1 papers (2020–2020)Alex F. Herrera · City Of Hope National Medical Center1 papers (2020–2020)Yi‐Bin Chen · Broad Institute1 papers (2020–2020)Vincent T. Ho · Harvard Stem Cell Institute1 papers (2020–2020)Ephraim P. Hochberg · University of Alabama at Birmingham1 papers (2019–2019)Augustine Weber · Dana-Farber Cancer Institute1 papers (2020–2020)